JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area cell cycle c myc'

Search results for: 'research area cell cycle c myc'

A8183 Trichostatin A (TSA)

13 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; ≥15.12 mg/mL
A3818 Silvestrol

Summary: Antineoplastic

Soluble in DMSO
A3433 Gefitinib hydrochloride

Target: EGFR

Summary: Potent EGFR inhibitor

insoluble in EtOH; ≥4.28 mg/mL
A8628 Chloroquine diphosphate

1 Citation

Target: Autophagy

Summary: Antimalarial drug,TLR7 TLR9 inhibitor

insoluble in DMSO; insoluble in EtOH; ≥106.06 mg/mL
A4090 JNJ-26481585

3 Citation

Target: Histone Deacetylases (HDACs)

Summary: Potent HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.2 mg/mL
A4071 Fluorouracil (Adrucil)

3 Citation

Target: Thymidylate Synthase

Summary: Antitumor agent;inhibitor of thymidylate synthase

insoluble in EtOH; ≥10.04 mg/mL
A8322 Neratinib (HKI-272)

1 Citation

Target: EGFR

Summary: HER2/EGFR inhibitor,potent and irreversible

insoluble in H2O; ≥13.93 mg/mL
A3149 AKT inhibitor VIII

2 Citation

Target: Akt

Summary: Allosteric Akt kinase inhibitor

insoluble in H2O; insoluble in EtOH; ≥9.2 mg/mL
A8208 Tariquidar

2 Citation

Target: P-glycoprotein (P-gp)

Summary: P-glycoprotein inhibitor,potent and non-competitive

insoluble in H2O; insoluble in EtOH; ≥16.17 mg/mL
A4512 Cucurbitacin I

Target: STAT|JAK

Summary: STAT3/JAK2 signaling inhibitor

≥22.45 mg/mL